Analyst Ratings for Biomea Fusion
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 17 analysts have published their opinion on Biomea Fusion (NASDAQ:BMEA) stock, with an average 12-month price target of $37.82, up 20.06% from the previous average of $31.50. The majority of the ratings are bullish.
May 18, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomea Fusion (NASDAQ:BMEA) has received 17 analyst ratings in the past 3 months, with an average 12-month price target of $37.82, a 20.06% increase from the previous average.
The majority of the 17 analyst ratings for Biomea Fusion are bullish, indicating a positive outlook for the stock. The average 12-month price target has increased by 20.06% from the previous average, suggesting that analysts believe the stock has potential for growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100